[English] 日本語
Yorodumi- PDB-7jg3: Human GAR transformylase in complex with GAR substrate and AGF103... -
+Open data
-Basic information
Entry | Database: PDB / ID: 7jg3 | ||||||
---|---|---|---|---|---|---|---|
Title | Human GAR transformylase in complex with GAR substrate and AGF103 inhibitor | ||||||
Components | Trifunctional purine biosynthetic protein adenosine-3 | ||||||
Keywords | LIGASE/LIGASE INHIBITOR / GARFTase / formyltransferase / transformylase / enzyme protein inhibitor / metabolism / alpha beta protein / Rossman fold / LIGASE / LIGASE-LIGASE INHIBITOR complex | ||||||
Function / homology | Function and homology information phosphoribosylformylglycinamidine cyclo-ligase / phosphoribosylformylglycinamidine cyclo-ligase activity / adenine biosynthetic process / phosphoribosylamine-glycine ligase / phosphoribosylamine-glycine ligase activity / phosphoribosylglycinamide formyltransferase 1 / purine ribonucleoside monophosphate biosynthetic process / phosphoribosylglycinamide formyltransferase activity / 'de novo' XMP biosynthetic process / brainstem development ...phosphoribosylformylglycinamidine cyclo-ligase / phosphoribosylformylglycinamidine cyclo-ligase activity / adenine biosynthetic process / phosphoribosylamine-glycine ligase / phosphoribosylamine-glycine ligase activity / phosphoribosylglycinamide formyltransferase 1 / purine ribonucleoside monophosphate biosynthetic process / phosphoribosylglycinamide formyltransferase activity / 'de novo' XMP biosynthetic process / brainstem development / Purine ribonucleoside monophosphate biosynthesis / glycine metabolic process / 'de novo' AMP biosynthetic process / purine nucleotide biosynthetic process / GMP biosynthetic process / 'de novo' IMP biosynthetic process / tetrahydrofolate biosynthetic process / cerebellum development / cerebral cortex development / extracellular exosome / ATP binding / metal ion binding / cytosol Similarity search - Function | ||||||
Biological species | Homo sapiens (human) | ||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2.091 Å | ||||||
Authors | Wong-Roushar, J. / Dann III, C.E. | ||||||
Funding support | United States, 1items
| ||||||
Citation | Journal: Bioorg.Med.Chem. / Year: 2021 Title: Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide ...Title: Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors Authors: Wallace-Povirk, A. / Tong, N. / Wong-Roushar, J. / O'Connor, C. / Zhou, X. / Hou, Z. / Bao, X. / Garcia, G.E. / Li, J. / Kim, S. / Dann, C.E. / Matherly, L.H. / Gangjee, A. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 7jg3.cif.gz | 103.3 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb7jg3.ent.gz | 76.2 KB | Display | PDB format |
PDBx/mmJSON format | 7jg3.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 7jg3_validation.pdf.gz | 964.5 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 7jg3_full_validation.pdf.gz | 967.2 KB | Display | |
Data in XML | 7jg3_validation.xml.gz | 11.4 KB | Display | |
Data in CIF | 7jg3_validation.cif.gz | 15.5 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/jg/7jg3 ftp://data.pdbj.org/pub/pdb/validation_reports/jg/7jg3 | HTTPS FTP |
-Related structure data
Related structure data | 7jg0C 7jg4C 5j9fS C: citing same article (ref.) S: Starting model for refinement |
---|---|
Similar structure data |
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-Components
#1: Protein | Mass: 22810.139 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: GART, PGFT, PRGS / Plasmid: pHis-parallel / Production host: Escherichia coli BL21(DE3) (bacteria) / Strain (production host): BL21(DE3) / Variant (production host): Rosetta pLysS References: UniProt: P22102, phosphoribosylamine-glycine ligase, phosphoribosylformylglycinamidine cyclo-ligase, phosphoribosylglycinamide formyltransferase 1 |
---|---|
#2: Chemical | ChemComp-GAR / |
#3: Chemical | ChemComp-V9A / |
#4: Chemical | ChemComp-NA / |
#5: Water | ChemComp-HOH / |
Has ligand of interest | Y |
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 3.52 Å3/Da / Density % sol: 65.07 % |
---|---|
Crystal grow | Temperature: 277 K / Method: vapor diffusion, hanging drop / pH: 7.5 Details: 0.1 M Tris (pH 7.5), 0.333 mM NaCl, 20% polyethylene glycol (PEG) 4000, and 2% PEG 400 |
-Data collection
Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: ALS / Beamline: 4.2.2 / Wavelength: 1 Å |
Detector | Type: RDI CMOS_8M / Detector: CMOS / Date: May 29, 2020 |
Radiation | Monochromator: GRAPHITE / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
Reflection | Resolution: 2.09→39.541 Å / Num. obs: 18747 / % possible obs: 99.8 % / Redundancy: 10.3 % / Biso Wilson estimate: 33.4 Å2 / CC1/2: 0.998 / Rmerge(I) obs: 0.143 / Rpim(I) all: 0.047 / Rrim(I) all: 0.151 / Net I/σ(I): 14.1 |
Reflection shell | Resolution: 2.09→2.15 Å / Redundancy: 9.4 % / Rmerge(I) obs: 1.757 / Mean I/σ(I) obs: 1.1 / Num. unique obs: 18747 / CC1/2: 0.51 / Rpim(I) all: 0.907 / Rrim(I) all: 1.858 / % possible all: 97.7 |
-Phasing
Phasing | Method: molecular replacement |
---|
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT Starting model: 5j9F Resolution: 2.091→39.541 Å / SU ML: 0.27 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 26.33 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso max: 124.89 Å2 / Biso mean: 45.7681 Å2 / Biso min: 19.15 Å2 | ||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: final / Resolution: 2.091→39.541 Å
| ||||||||||||||||||||||||||||||||||||||||||
LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0
| ||||||||||||||||||||||||||||||||||||||||||
Refinement TLS params. | Method: refined / Origin x: -31.5627 Å / Origin y: 18.8872 Å / Origin z: 27.9829 Å
| ||||||||||||||||||||||||||||||||||||||||||
Refinement TLS group |
|